Author

John Peter Perentesis

Cincinnati Children's Hospital Medical CenterORCID 0000-0002-4237-8226Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Andrew J. CarrolliD· 1 shared Ann‐Kathrin EisfeldiD· 1 shared Anthony Joseph Paravati· 1 shared Bayard L. Powell· 1 shared Benjamin WronowskiiD· 1 shared Brett VanCauwenbergh· 1 shared Carolyn M. CheneyiD· 1 shared Casie Furby· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew J. CarrollORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PTPN11 Mutation Clonal Hierarchy in Acute Myeloid Leukemia

Sydney Fobare, Chia Sharpe, K. R. Quinn, Kinsey Bryant, Linde A. Miles, Robert L. Bowman, Carolyn M. Cheney, Casie Furby, Marissa Long, Kaytlynn Fyock, Benjamin Wronowski, James R. Lerma, Krzysztof Mrózek, Deedra Nicolet, Thomas M. Sesterhenn, , John C. Byrd

This study identifies PTPN11 mutations as potential initiating events in AML when paired with NPM1 mutations, revealing their co-driver role and immune diversity in patient samples.

JCI Insight · Feb 23, 2026Peer-reviewedCancer Biology

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines.

Matthew C. Garrett, Troy Carnwath, Rebecca Albano, Yonghua Zhuang, Catherine A. Behrmann, Merissa Pemberton, Farah Barakat, Robert M. Lober, Mark Hoeprich, Anthony Joseph Paravati, Marilyn Reed, Hailey Spry, Daniel Woo, Eric Justin O'Brien, Brett VanCauwenbergh, , David R. Plas

This study identifies CPI203, a BET inhibitor, as a compound that consistently down-regulates DNA synthesis genes across multiple glioblastoma lines.

PLoS ONE · May 16, 2025Peer-reviewedCancer Biology